Michael Gray - CFO & COO at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Cfo & Coo
Stock Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael Gray since 8/15/2023

Holdings reported by Michael Gray for Enliven Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 27.6K $418K $15.14 Feb 22, 2023 Direct

Transactions reported by Michael Gray for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership